US07718896B1
In communication cable of high capacity according to present invention, conductor of diameter d is coated by insulation material to form wire of diameter D, plural number of said wire are twisted by pitch p to form pairs, plural number of said pairs are twisted by collective pitch P, and said communication cable of high capacity comprise sheath wrapping said pairs, and the diameter d of said conductor and diameter D of said wire and pitch p and collective pitch P and impedance of said wires are defined by function of compensation coefficient A (81
US07718892B2
A housing unit for securing electronics of a control module to a vehicle may include a housing and at least two connection members. The connection members connected to the housing may be adapted to engage an adaptor member (e.g., bracket) configured to be secured to a vehicle. The connection members may include at least one connection member configured to hook into the adaptor member and at least one connection member configured to snap into the adaptor member. Protrusion(s) may be included on the connection member(s) and be configured to contact the adaptor member to substantially eliminate transverse movement of the housing. The protrusion(s) may be crush-rib(s). The housing may include features to position, support, and minimize vibration of the electronics, where the electronics maybe disposed on a printed circuit board (PCB).
US07718877B2
The invention relates to a device for setting skin tension, in particular for use in a musical instrument such as a kettledrum. The device comprises a tensioning star provided with an engaging element for engaging an operating mechanism for adjusting the tensioning star in an axial adjusting direction, substantially parallel to a central axis of the tensioning star. The tensioning star is also provided with a plurality of arms extending substantially in radial directions of which at least a part is provided with a coupling element for coupling to a tensioning rod construction attachable to the skin. In addition, the device comprises an adjusting device for adjusting the distance between a coupling element and the central axis of the tensioning star.
US07718870B1
According to the invention, there is provided seed and plants of the hybrid corn variety designated CH771816. The invention thus relates to the plants, seeds and tissue cultures of the variety CH771816, and to methods for producing a corn plant produced by crossing a corn plant of variety CH771816 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH771816.
US07718859B2
According to the invention, there is provided seed and plants of the corn variety designated CV391950. The invention thus relates to the plants, seeds and tissue cultures of the variety CV391950, and to methods for producing a corn plant produced by crossing a corn plant of variety CV391950 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety CV391950 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety CV391950.
US07718854B2
The invention relates to the novel cotton variety designated 04T042. Provided by the invention are the seeds, plants, plant parts and derivatives of the cotton variety 04T042. Also provided by the invention are tissue cultures of the cotton variety 04T042 and the plants regenerated therefrom. Still further provided by the invention are methods for producing cotton plants by crossing the cotton variety 04T042 with itself or another cotton variety and plants produced by such methods.
US07718850B2
The invention relates to methods and compositions for modulating properties of fruit dehiscence in plants such Brassicaceae plants, specifically to improved methods and means for reducing seed shattering in Brassicaceae plants, particularly the Brassicaceae plants grown for oil production, to a degree which is agronomically important.
US07718842B2
The invention concerns a process for separating meta-xylene from a hydrocarbon feed comprising isomers containing 8 carbon atoms, comprising: a step for bringing said feed into contact with a faujasite type zeolite adsorbant, the percentage of water in the adsorbant being in the range 0 to 8% by weight and the adsorption temperature being from 25° C. to 250° C.; a desorption step employing a solvent selected from tetraline and its alkylated derivatives; a step for separating meta-xylene from the desorbant.
US07718836B2
The present invention relates to an integrated process for the production of high purity 2,6-dimethylnaphthalene starting from hydrocarbon mixtures containing naphthalene and/or isomers of methylnaphthalene and/or isomers of dimethylnaphthalene and/or isomers of polymethylnaphthalene, and from an alkylating agent, preferably methanol, reacted in the presence of a methylated benzene solvent or mixture of various methylated benzene solvents, preferably selected from toluene, xylene and trimethylbenzene, and a catalyst consisting of ZSM-12 zeolite and an inorganic ligand.
US07718835B2
Disclosed herein is a process of producing high purity and high yield dimethylnaphthalene by dehydrogenating a dimethyltetralin isomer using a metal catalyst for dehydrogenation. The metal catalyst contains a carrier selected from alumina (Al2O3), silica (SiO2), a silica-alumina mixture and zeolite. The metal catalyst also contains 0.05 to 2.5% by weight of platinum (Pt), 0.1 to 3.0% by weight of tin (Sn) or indium (In), 0.5 to 15.0% by weight of at least one selected from the group consisting of potassium (K), magnesium (Mg) and cesium (Cs), 0.3 to 3.0% by weight of chlorine, and 0.01 to 3.0 % by weight of zinc (Zn) or gallium (Ga) as active components based on an element weight of the final catalyst.
US07718834B2
A method for preparing linear long chain fatty alcohols having 20 to 40 carbon atoms by a growth reaction of ethylene on aluminum compounds.
US07718833B2
Methods for purifying glycerin contaminated with one or more lower boiling alcohols such as methanol, ethanol, straight, branched or cyclic C3-C6 alcohols, and the like. The methods are particularly useful for purifying crude glycerin phases recovered from the synthesis of biofuels. The present invention uses distillation techniques to strip alcohol contaminants from glycerin. In contrast to conventional methods that carry out distillation either under substantially anhydrous or very wet conditions, the present invention carries out distillation in the presence of a limited amount of water, e.g., from about 0.8 to about 5 parts by weight of water per 100 parts by weight of contaminated glycerin to be purified.
US07718825B2
A process for converting an arylamine into an arylamine derivative, includes (i) providing a first arylamine compound; (ii) formylating the first arylamine compound to form a formyl substituted arylamine compound, where the first arylamine compound is not a formyl substituted arylamine compound; and (iii) acidifying the formyl substituted arylamine compound, in the presence of a solvent and a solid organic catalyst, to convert formyl functional groups into acid functional groups to form an acidified compound.
US07718823B2
This invention relates to toluate ester compositions and their use as solvent, plasticizers, extender and/or diluents in binder formulations, a method of producing such ester compositions, as well as polymer compositions containing such liquid ester compositions. The method of making toluate based esters by reacting methyl-p-toluate with ethylene glycol, diethylene or triethylene glycol, butanediol, etc. More particularly, this invention relates to the mono- or di-ester of methyl toluic acid with a diol containing 2 to 6 carbon atoms that are low viscosity liquids at 25° C. The most common polymer that employs plasticizer is polyvinyl chloride (PVC). Typical amounts of plasticizer in PVC are from about 3 wt. % to about 50 wt. %. Phenolic resins generally require solvents, diluents and/or extenders that reduce the volatility and viscosity of the resin, especially when it is used in building and automotive products. Typical amounts of solvent are from about 5 wt. % to about 65 wt. %.
US07718822B2
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
US07718821B1
This invention relates to a process for producing electron deficient olefins, such as 2-cyanoacrylates, using an iminium salt.
US07718812B2
The invention relates to a process for the conversion of group X in a 2-(6-substituted)-1,3-dioxane-4yl) acetic acid derivative according to formula 2 into a group OY in the presence of a phase transfer catalyst and an oxylating agent, by using as a phase transfer catalyst a quarternary phosphonium ion and by using as an oxylating agent an OY-ion. X stands for a halogen and R1, R2 and R3 are each independently a C1–4 alkylgroup or R1 and R2 together with the C-atom to which they are bound form a 5- or 6-membered cycloalkyl; Y stands for RA-CO— or for RB—SO2- with RA, RB are chosen from the group of alkyl or aryl with 1–12 C-atoms.
US07718789B2
Novel isolated plant polynucleotide promoter sequences are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.
US07718786B2
Ligation-mediated method of recombining polynucleotides in vitro. Polynucleotides from a library are fragmented and the fragments are hybridized to an assembly template. The hybridized fragments are iteratively re-hybridized and ligated until the ends of the hybridized fragments are adjacent to the ends of other hybridized fragments on the assembly template. A final ligation produces recombined polynucleotides.
US07718784B2
In one embodiment, the present invention relates to fluorescent nucleic acid constructs and methods of using these switchable constructs to rapidly screen for target molecule interactions. More particularly, an RNA/DNA chimera comprising a fluorophore-quencher pair and a nucleic acid construct is disclosed for the rapid screening of interactions between the HIV-1 nucleocapsid protein, NCp7, and a stem-loop region, SL3, of the HIV-1 RNA, or antagonists thereof. The compositions and methods disclosed herein can be used in preferred aspects of the present invention for diagnosing disease states, distinguishing the presence of infectious or toxic agents, drug discovery and design, and molecular electronic applications.
US07718781B2
The present invention provides hydroxypyridinone and hydroxypyrimidone chelating agents. Also provides are Gd(III) complexes of these agents, which are useful as contrast enhancing agents for magnetic resonance imaging. The invention also provides methods of preparing the compounds of the invention, as well as methods of using the compounds in magnetic resonance imaging applications.
US07718776B2
Monoclonal antibodies and hybridomas producing them that interact with osteoprotegerin ligand (OPGL) are provided. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are also provided. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are further provided.
US07718752B2
A process for producing a resorcinol-formalin resin containing no salts, having a moderate flowability when transformed into an aqueous solution, and having a reduced content of resorcinol monomer and a reduced content of resorcinol-formalin resin of resorcinol pentanuclear or higher nuclear bodies, the whole steps including an one-stage reaction and liquid-liquid distribution being conducted in the same reactor, which comprises adding resorcinol, an inorganic salt, and an organic solvent having a solubility parameter of 7.0 to 12.5 to a water solvent, stirring the mixture to give a two-phase system containing no remaining solid matter, adding an acid catalyst, adding formalin dropwise into the reaction system to cause a liquid-liquid heterogeneous reaction to proceed, removing the aqueous layer, adding an organic solvent and water to the reaction product layer, the amount of the water being half of the amount of the organic solvent, stirring the resulting mixture, allowing it to stand, and then removing the aqueous layer to obtain the resorcinol-formalin resin.
US07718751B2
The present invention concerns a pre-mix for a syntactic phenolic foam composition; a syntactic phenolic foam composition; and a process for preparing the syntactic phenolic foam composition.The pre-mix comprises thermally expandable and/or expanded thermoplastic microspheres, the microspheres comprising a thermoplastic polymer shell made of a homopolymer or copolymer of 100 to 25, for example 93 to 40, parts by weight of a nitrile-containing, ethylenically unsaturated monomer, or a mixture thereof; and 0 to 75, for example 7 to 60, parts by weight of a non-nitrile-containing, ethylenically unsaturated monomer, or a mixture thereof; and a propellant, or a mixture thereof, trapped within the thermoplastic polymer shell; and one of either a highly reactive phenolic resole resin capable of fully crosslinking at temperatures between 15° C. and 60° C., optionally in the presence of up to ten times its own weight in water, and having, typically, a free phenol content of 12-15% (w/w); or an acidic catalyst for curing the phenolic resole resin.The process comprises either curing the above-mentioned pre-mix in the presence of the other of the acidic catalyst; and the highly reactive phenolic resole resin, as defined above or, alternatively, curing all three components, together with any other components.
US07718750B2
The present invention is directed to organo-silicone compound that have alkoxylated allyl alcohol groups of different degree of ethylene oxide and or propylene oxide present on two or more different groups. It is also directed to the use of that compound in personal care and other applications. These compounds by virtue of their unique structure provide outstanding emulsions including microemulsions.
US07718730B2
A two-component adhesive, sealant, or coating composition containing (i) a first component containing a portion of an alkoxysilane-functional urethane and water; and (ii) a second component containing the remaining portion of the alkoxysilane-functional urethane and a catalyst. The alkoxysilane-functional urethane includes the reaction product of (a) the reaction product of a hydroxy functional compound and a polyisocyanate, that contains isocyanate groups; with (b) an amine functional aspartate. The composition is used in a method of bonding a first substrate to a second substrate. The method includes (a) combining component i) and component ii) to form a mixture, applying a coating of the mixture to at least one surface of the first substrate or the second substrate, and contacting a surface of the first substrate with a surface of the second substrate. The method is used make an assembly.
US07718728B2
This invention relates to a rubber composition having a high interaction between rubber component and carbon black, a good wear resistance and an excellent low heat buildup (low hysteresis loss), and more particularly to a rubber composition comprising (A) 100 parts by mass of a rubber component containing not less than 10% by mass of a conjugated diene polymer having a polymer chain with at least one functional group selected from the group consisting of particular substituted amino group and cyclic amino group, (B) not less than 20 parts by mass of carbon black and (C) not more than 1.0 part by mass of a polycyclic aromatic compound (PCA).
US07718727B2
Fluoroplastics containing fluorocarbon resins and silicones are prepared by first mixing a fluorocarbon resin with a compatibilizer, then adding a curable organopolysiloxane with a radical initiator, and vulcanizing the organopolysiloxane in the mixture. The fluoroplastics can be processed by various techniques, such as extrusion, vacuum forming, injection molding, blow molding or compression molding, to fabricate plastic parts. The resulting fabricated parts can be re-processed (recycled) with little or no degradation of mechanical properties.
US07718719B2
A method of stabilizing a normally solid polyalkylene carbonate resin against thermal and hydrolytic decomposition, including the step of adding a cyclic amine selected from the group consisting of imidazole and 2-ethyl 4-methylimidazole at a wt. % of 5 to 45% of the normally solid polycarbonate resin. And, a method of producing tough coatings with excellent adhesion to both ferrous and non-ferrous metals, including the steps of: a) dissolving polyalkylene carbonate resin and a cyclic amine selected from the group of consisting of imidazole and 2-ethyl 4-methylimidazole at a wt. % of 5 to 45% of the normally solid polycarbonate resin in a solvent selected from the group consisting of methyl ethyl ketone and propylene glycol mono methyl ether acetate by mechanical mixing so as to form a solution; b) coating the ferrous or non-ferrous metals with the solution so as to form a coated metal; c) air drying the coated metal to evaporate the solvent so as to form an air-dried coated metal; and, d) curing the air-dried coated metal for a time selected from the group consisting of at least 12 hours at ambient temperature and 15 minutes at 150° C.
US07718714B2
An actinic energy ray-curable resin is obtained by reacting an unsaturated monocarboxylic acid (c) with a terminal epoxy group of an epoxy resin having an unsaturated group and a hydroxyl group in its side chains and an epoxy group in its terminal and further reacting a polybasic acid anhydride (d) with the hydroxyl group of the above-mentioned epoxy resin, wherein the above-mentioned epoxy resin is a product of the polyaddition reaction of a reaction product (I) of a polybasic acid anhydride (a) and a compound (b) having at least one unsaturated double bond and one alcoholic hydroxyl group in its molecule, a compound (II) having at least two carboxyl groups in its molecule, and a bifunctional epoxy compound (III), wherein at least either one of the carboxyl group-containing compound (II) and the bifunctional epoxy compound (III) is a compound containing no aromatic ring. A photocurable and thermosetting resin composition comprising this actinic energy ray-curable resin, a photopolymerization initiator, a diluent, and a cyclic ether compound is useful as a solder resist for a printed circuit board, interlaminar insulating materials for a multi-layer printed circuit board, and the like.
US07718709B2
A fat or oil composition comprising a polyvalent unsaturated fatty acid component and an emulsifying agent having an HLB of 4 or less, wherein the amount of the emulsifying agent having an HLB of 4 or less is from 25 to 300 parts by weight, based on 100 parts by weight of the polyvalent unsaturated fatty acid component. The fat or oil composition can be used as an oil-in-water droplet emulsion composition. The fat or oil composition and the oil-in-water droplet emulsion composition can be used for foodstuff and the like.
US07718698B2
The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amid, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above.
US07718688B2
The present invention relates generally to nitro-1,2-dihydro-3H-benzo[e]indoles and related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.
US07718687B2
The present invention relates to prodrugs of dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
US07718685B2
The present invention relates to 4,5-bis(4-methoxyphenyl)imidazole compound inducing differentiation of myoblasts or muscle fibers into neuron cells and a pharmaceutical composition including said compound. More specifically, it relates to 2-(2-fluorenyl)-4,5-bis(4-methoxyphenyl)imidazole that induces differentiation of myoblasts or muscle fibers, all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug thereof, and a pharmaceutical composition including said compound.
US07718683B2
Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists and as controls in assays for the identification of CCR9 antagonists.
US07718682B2
Novel diphenylethylene compounds and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes. The compounds are disclosed as useful for a variety of treatments including the treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis.
US07718678B2
Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof. X is N or N+O−, and Y is N or N+O−, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine-mediated diseases such as COPD.
US07718676B2
The present invention relates to novel compounds selected from 2-aminoaryloxazoles of formula I that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit, bcr-abl, FGFR3 and/or Flt-3 inhibitors.
US07718675B2
The application relates to novel amino alcohols of the general formula (I) where R, R1, R2, R3, R4, R5 and R6 each have the definitions illustrated in detail in the description, to a process for their preparation, and to the use of these compounds as medicines, in particular as renin inhibitors.
US07718669B2
The invention relates to triazolopyridine derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
US07718664B2
A method of inhibiting or reducing occurrence or intensity of pruritus including administering to a patient an effective amount of one or more of the morphinan derivative having a nitrogen-containing cyclic group of the Formula (Ia): wherein R1 is cyclopropylmethyl; R2 and R3 are independently hydrogen, hydroxy, C1-C5 alkoxy, C3-C7 alkenyloxy, C7-C13 aralkyloxy or C1-C5 alkanoyloxy; and the Formula (Ia) includes (+), (−) and (±) isomers or the pharmaceutically acceptable acid addition salt thereof.
US07718663B2
An object of the present invention is to provide an antipruritic agent having a novel action mechanism.The present invention provides an antipruritic agent comprising a compound represented by the following general formula (1): wherein R1 represents a hydrogen atom or alkyl; the ring Q represents a cyclohexylene group or a phenylene group; A1 and A2 represent a single bond or an alkylene group; E represents —NHCO—; A3 represents a single bond or a divalent saturated or unsaturated aliphatic hydrocarbon group; R3 represents a non-cyclic aliphatic hydrocarbon group; and R4 and R5 are the same or different and each represents a hydrogen atom or alkyl, or a pharmaceutically acceptable salt thereof as an active ingredient.
US07718659B2
The invention is concerned with novel heteroarylacetamides of formula (I) Rd—C(O)—N(Re)—Rc—CH2—C(O)—N(Ra)(Rb) (I) wherein Ra to Re are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
US07718655B2
Trisubstituted triazines can be synthesized from cyanuric chloride. These compounds are useful anti-tubulin agents for treating cancer and proliferative diseases.
US07718652B2
The present invention is directed to substituted benzothiadiazinedioxide derivatives of formula I: or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders.
US07718647B2
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
US07718638B2
This invention discloses (20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs, and specifically (20R)-23,23-difluoro-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.
US07718637B2
This invention discloses (20S)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs, and specifically (20S)-23,23-difluoro-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity.
US07718636B2
This invention provides pharmaceutical uses for 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3. Administration of this compound increases the life expectancy of human beings, especially elderly human beings. In particular, it increases the survival rate of females lacking estrogen, especially post-menopausal females, and reduces mortality resulting from spontaneous development of malignant tumors in both males and females.
US07718631B2
The present invention provides three BCAS2 related nucleotide sequences. The present invention also provides a composition comprising a nucleotide sequence of small interfering RNA of BCAS2 gene. The present invention further provides a method for treating p53 containing cancer comprising administrating a subject with an effective amount of the said composition.
US07718630B2
Delta protein expression in a cell is reduced by introducing miR-1 into the cell, and detecting a resultant reduction of Delta protein expression in the cell.
US07718626B2
A method of repressing a cell-cycle gene, which is regulated by an E2F transcription factor, in a cell, wherein the method comprises contacting the cell with a cell-cycle gene-repressing amount of ErbB3 binding protein (Ebp1); a method of inhibiting prostate cancer in a mammal, wherein the method comprises administering to the mammal a prostate cancer-inhibiting amount of Ebp1; a composition comprising an Ebp1-expressing viral vector that expresses a cell-cycle gene-repressing amount of Ebp1; and a composition comprising polymer-packaged DNA comprising and expressing a cell-cycle gene-repressing amount of Ebp1.
US07718623B2
An immunostimulatory oligonucleotide that is represented by the general formula 5′-Gm-GACGATCGTC-Gn-3′ or 5′-Gm-CACGATCGTG-Gn-3′ (in the formula, m and n are each independently an integer from 1 to 9 and m+n=10) and that comprises any of the following base sequences: GGACGATCGTCGGGGGGGGG (SEQ. ID. NO.: 1), GGGACGATCGTCGGGGGGGG (SEQ. ID. NO.: 2), GGGGACGATCGTCGGGGGGG (SEQ. ID. NO.: 3), GGGGGGGACGATCGTCGGGG (SEQ ID NO: 4), GGGGGGGGACGATCGTCGGG (SEQ. ID. NO.: 5), GGGGGGGGGACGATCGTCGG (SEQ. ID. NO.: 6), GGGGGGGGGGACGATCGTCG (SEQ. ID. NO.: 7), and GGGGGGGGGCACGATCGTGG (SEQ. ID. NO.: 8).
US07718613B2
This invention relates to peptides useful for releasing active agent in the fields of diagnostics and drug delivery.
US07718610B2
Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens.
US07718608B2
Disclosed are methods of treating a subject suffering from irritable bowel syndrome which involves administering rifaximin to the subject and reducing the symptoms of irritable bowel syndrome. Also disclosed are methods of improving the symptoms in a subject caused by irritable bowel syndrome.
US07718604B2
The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.
US07718600B2
Compounds that bind cellular IAPs (inhibitor of apoptosis proteins) are disclosed. The compounds are mimetics of the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABOLO, IIid, Grim and Reaper, which interact with a specific surface groove of IAP. Also disclosed are methods of using these compounds for therapeutic, diagnostic and assay purposes.
US07718596B2
A unit dose fabric treatment system comprises a water soluble container in which a liquid fabric treatment composition is disposed, the composition comprising one or more fatty acid esters wherein, in at least one of the fatty acid esters, the average proportion of C18 chains is less than 60%, preferably less than 50%, more preferably less than 40%, e.g. less than 30% by weight of the total weight of fatty acid chains in the fatty acid ester.
US07718595B2
The invention encompasses liquid cleaning compositions, for example, dish washing liquids, and methods of their manufacture and use, which possess enhanced cleaning ability. The cleaning compositions of the invention include acidic light duty liquid cleaning compositions with low toxicity and antibacterial efficacy on surfaces, for example, hard surfaces.
US07718594B1
The current invention encompasses a microemulsion having environmentally safe components, the microemulsion exhibiting optical clarity and stability over a wide range of temperatures. The microemulsion also forms a part of a decontaminant solution for treating chemical and biological contaminant agents, the solution preferably containing peroxycarboxylic acids generated from solids as the primary decontamination agent. The solution is a single phase emulsion that is both stable and effective over a broad range of temperatures, the range extending well below 0° C. There is also disclosed a microemulsion decontaminate solution having components that stabilize the included solid and peroxycarboxylic acids.
US07718592B2
Coated sodium percarbonate particles, having an inner shell layer which comprises at least one inorganic, hydrate-forming salt as the main constituent, and an outer shell layer which comprises an alkali metal thiosulfate, an alkaline earth metal thiosulfate and/or an ammonium thiosulfate, are stable to storage and have an improved storage stability in detergents and cleaning agents. Detergents and cleaning agents which comprise such sodium percarbonate particles show a reduced oxidative attack on oxidation-sensitive constituents of the composition during storage. Machine dishwashing agents in the form of tablets which comprise such sodium percarbonate particles and a corrosion protection agent for silver show a reduced yellowing of the tablets during storage.
US07718590B2
A variety of compositions that are particularly applicable for removing one or more of resist, etching residue, planarization residue, and copper oxide from a substrate comprising copper and a low-k dielectric material are described. The resist, residues, and copper oxide are removed by contacting the substrate surface with the composition, typically for a period of 30 seconds to 30 minutes, and at a temperature between 25° and 45° C. The composition includes a fluoride-providing component; at least 1% by weight of a water miscible organic solvent; an organic acid; and at least 81% by weight water. Typically the composition further includes up to about 0.4% of one or more chelators.
US07718587B2
A lubricant composition is provided for use in lubricating a conveyor track for bottles, cans, kegs and other containers for beverages and foodstuffs. The composition comprises a phosphate ester of the formula R1—(OCH2CH2)n—O—P(O)(OH)2 where n is in the range of from 0 to 10, and R1 is a C9 to C20 saturated or unsaturated alkyl group or a mixture of such alkyl groups; and water. The composition has a pH of from about 1 to about 3.5. The composition optionally further comprises a biocidal agent, an acid, and a synthetic surfactant. Also disclosed is a method for lubricating a conveyor track by applying an effective amount of such a lubricating composition.
US07718586B2
Disclosed is composition useful for reducing the concentration of mercaptans in hydrocarbons comprising: (A) a first diazo component and (B) a second component comprising a nucleophilic acceptor. The composition can be added to hydrocarbons such as fuel oil to reduce mercaptans without increasing turbidity or color. Triethylene diamine and 1,2-epoxyhexadecane are disclosed to be exemplary diazo and nucleophilic acceptor components.
US07718581B2
A method of reducing wear in a cutting head of a tunnel boring machine, by means of the addition at the cutting head of a foamed aqueous liquid composition, which comprises a foaming agent and a lubricant, the lubricant being selected from the group consisting of high molecular weight polyethylene oxides and bentonite. Preferred foaming agents are anionic and nonionic surfactants. Wear rates of cutting elements of TBMs boring in hard rock are considerably reduced. A wear-reducing foamable concentrate is also described.
US07718580B2
The present invention provides an internal olefin composition comprising a mixture of 60 to 80% by mass of an olefin having 16 carbon atoms and 40 to 20% by mass of an olefin having 18 carbon atoms wherein a content of an α-olefin in the mixture is 10% by mass or less, and a content of a branched olefin in the mixture is 10% by mass or less, which has a good biodegradability even when discharged into the environments, a less toxicity against marine organisms, etc., and a sufficient fluidity when used as a base oil for oil drilling, etc.
US07718574B2
Methods for depositing, at a very high deposition rate, a biaxially-textured film on a continuously moving metal tape substrate are disclosed. These methods comprise: depositing a film on the substrate with a deposition flux having an oblique incident angle of about 5° to about 80° from the substrate normal, while simultaneously bombarding the deposited film using an ion beam at an ion beam incident angle arranged along either a best ion texture direction of the film or along a second best ion texture direction of the film, thereby forming the biaxially-textured film, wherein a deposition flux incident plane is arranged parallel to a direction along which the biaxially-textured film has a fast in-plane growth rate. Superconducting articles comprising a substrate, a biaxially-textured film deposited on said substrate by said methods above; and a superconducting layer disposed on the biaxially-textured film are also disclosed.
US07718572B2
An aqueous microcapsule suspension liquid exhibiting an excellent (long-term) storage stability and allowing easy re-dispersion and dilution with water even after such a storage, is produced by adding a microorganism-fermented polysaccharide of succinoglycan type as a thickening agent into a microcapsule slurry, or by adding such a microorganism-fermented polysaccharide as a thickening agent to a microcapsule slurry after uniform dilution with water.
US07718561B2
The present invention relates to a catalyst for preparing phthalic anhydride by gas phase oxidation of o-xylene and/or naphthalene, comprising at least three catalyst zones which have different compositions and, from the gas inlet side toward the gas outlet side, are referred to as first, second and third catalyst zone, the catalyst zones having in each case an active composition comprising TiO2, and the active composition content decreasing from the first catalyst zone disposed toward the gas inlet side to the third catalyst zone disposed toward the gas outlet side, with the proviso that (a) the first catalyst zone has an active composition content between about 7 and 12% by weight, (b) the second catalyst zone has an active composition content in the range between 6 and 11% by weight, the active composition content of the second catalyst zone being less than or equal to the active composition content of the first catalyst zone, and (c) the third catalyst zone has an active composition content in the range between 5 and 10% by weight, the active composition content of the third catalyst zone being less than or equal to the active composition content of the second catalyst zone. Also described is a preferred process for preparing such a catalyst and the preferred use of the titanium dioxide used in accordance with the invention.
US07718559B2
A method of fabricating doped quartz component is provided herein. In one embodiment, the doped quartz component is a yttrium doped quartz ring configured to support a substrate. In another embodiment, the doped quartz component is a yttrium and aluminum doped cover ring. In yet another embodiment, the doped quartz component is a yttrium, aluminum and nitrogen containing cover ring.
US07718556B2
A medical film that is excellent in biocompatibility and bioabsorbability and has an excellent strength in suturing and bonding is provided. A reinforcing material 12 made of a biodegradable polymer is placed in a gelatin solution so as to allow the solution to infiltrate in the reinforcing material 12 and then the gelatin is dried. This allows the gelatin that has infiltrated entirely in an internal part of the reinforcing material 12 to gel, thereby forming a gelatin film 11. Thus, a medical film 1 in which the reinforcing material 12 and the gelatin film 11 are integrated is obtained. The gelatin film 11 preferably is a cross-linked gelatin film.
US07718552B2
A method and device of nanostructured titania that is crack free. A method in accordance with the present invention comprises depositing a Ti film on a surface, depositing a masking layer on the Ti film, etching said masking layer to expose a limited region of the Ti film, the limited region being of an area less than a threshold area, oxidizing the exposed limited region of the Th.ucsbi film, and annealing the exposed limited region of the Ti film.
US07718549B2
A method of making a transistor having first and second electrodes, a semiconductive layer, and a dielectric layer; said semiconductive layer comprising a semiconductive polymer and said dielectric layer comprising an insulating polymer; characterised in that said method comprises the steps of: (i) depositing on the first electrode a layer of a solution containing material for forming the semiconductive layer and material for forming the dielectric layer; and (ii) optionally curing the layer deposited in step (i); wherein, in step (i), the solvent drying time, the temperature of the first electrode and the weight ratio, of (material for forming the dielectric layer): (material for forming the semiconductive layer) in the solution are selected so that the material for forming the semiconductive layer and the material for forming the dielectric layer phase separate by self-organisation to form an interface between the material for forming the semiconductive layer and the material for forming the dielectric layer.
US07718538B2
A pulsed plasma system with pulsed sample bias for etching semiconductor structures is described. In one embodiment, a portion of a sample is removed by applying a pulsed plasma process, wherein the pulsed plasma process comprises a plurality of duty cycles. A negative bias is applied to the sample during the ON state of each duty cycle, while a zero bias is applied to the sample during the OFF state of each duty cycle. In another embodiment, a first portion of a sample is removed by applying a continuous plasma process. The continuous plasma process is then terminated and a second portion of the sample is removed by applying a pulsed plasma process.
US07718529B2
Ultrafine dimensions, smaller than conventional lithographic capabilities, are formed employing an efficient inverse spacer technique comprising selectively removing spacers. Embodiments include forming a first mask pattern over a target layer, forming a spacer layer on the upper and side surfaces of the first mask pattern leaving intermediate spaces, depositing a material in the intermediate spacers leaving the spacer layer exposed, selectively removing the spacer layer to form a second mask pattern having openings exposing the target layer, and etching the target layer through the second mask pattern.
US07718525B2
Methods of forming a metal interconnect and an IC chip including the metal interconnect are disclosed. One embodiment of the method may include providing an integrated circuit (IC) chip up to and including a middle of line (MOL) layer, the MOL layer including a contact positioned within a first dielectric; recessing the first dielectric such that the contact extends beyond an upper surface of the first dielectric; forming a second dielectric over the first dielectric such that the second dielectric surrounds at least a portion of the contact, the second dielectric having a lower dielectric constant than the first dielectric; forming a planarizing layer over the second dielectric; forming an opening through the planarizing layer and into the second dielectric to the contact; and forming a metal in the opening to form the metal interconnect.
US07718518B2
A doped silicon layer is formed in a batch process chamber at low temperatures. The silicon precursor for the silicon layer formation is a polysilane, such as trisilane, and the dopant precursor is an n-type dopant, such as phosphine. The silicon precursor can be flowed into the process chamber with the flow of the dopant precursor or separately from the flow of the dopant precursor. Surprisingly, deposition rate is independent of dopant precursor flow, while dopant incorporation linearly increases with the dopant precursor flow.
US07718510B2
A laser processing method is provided, which, even when a substrate formed with a laminate part including a plurality of functional devices is thick, can cut the substrate and laminate part with a high precision.This laser processing method irradiates a substrate 4 with laser light L while using a rear face 21 as a laser light entrance surface and locating a light-converging point P within the substrate 4, so as to form modified regions 71, 72, 73 within the substrate 4. Here, the quality modified region 71 is formed at a position where the distance between the front face 3 of the substrate 4 and the end part of the quality modified region 71 on the front face side is 5 μm to 15 μm. When the quality modified region 71 is formed at such a position, a laminate part 16 (constituted by interlayer insulating films 17a, 17b here) formed on the front face 3 of the substrate 4 is also cut along a line to cut with a high precision together with the substrate 4.
US07718505B2
The method of forming a semiconductor structure in a substrate comprises, forming a first trench with a first width We and a second trench with a second width Wc, wherein the first width We is larger than the second width Wc, depositing a protection material, lining the first trench, covering the substrate surface and filling the second trench and removing partially the protection material, wherein a lower portion of the second trench remains filled with the protection material.
US07718502B2
A semiconductor apparatus includes a wiring pattern, an insulating film, and a thin-metal-film resistor element. The insulating film is formed on the wiring pattern having connection holes vertically penetrating there-through to expose part of the wiring pattern at bottom regions of the connection holes. The connection holes are arranged with a space there-between. The thin-metal-film resistor element is formed on the insulating film and extending to continuously overlay and contact surfaces of the insulating film, inner walls of the connection holes, and the wiring pattern at the bottom regions of the connection holes.
US07718498B2
A semiconductor device suitable for a source-follower circuit, provided with a gate electrode formed on a semiconductor substrate via a gate insulation film, a first conductivity type layer formed in the semiconductor substrate under a conductive portion of the gate electrode and containing a first conductivity type impurity, first source/drain regions of the first conductivity type impurity formed in the semiconductor substrate and extended from edge portions of the gate electrode, and second source/drain regions having a first conductivity type impurity concentration lower than that in the first source/drain regions and formed adjoining the gate insulation film and the first source/drain regions in the semiconductor substrate so as to overlap portions of the conductive portion of the gate electrode.
US07718489B2
A semiconductor structure and method for forming the same. The structure includes multiple fin regions disposed between first and second source/drain (S/D) regions. The structure further includes multiple front gates and back gates, each of which is sandwiched between two adjacent fin regions such that the front gates and back gates are alternating (i.e., one front gate then one back gate and then one front gate, and so on). The widths of the front gates are greater than the widths of the back gates. The capacitances of between the front gates and the S/D regions are smaller than the capacitances of between the back gates and the S/D regions. The distances between the front gates and the S/D regions are greater than the distances between the back gates and the S/D regions.
US07718487B2
A method of manufacturing a ferroelectric layer, including: forming a first ferroelectric layer above a base by a vapor phase method; and forming a second ferroelectric layer above the first ferroelectric layer by a liquid phase method.
US07718486B2
Methods and systems for fabricating integrated pairs of HBT/FET's are disclosed. One preferred embodiment comprises a method of fabricating an integrated pair of GaAs-based HBT and FET. The method comprises the steps of: growing a first set of epitaxial layers for fabricating the FET on a semi-insulating GaAs substrate; fabricating a highly doped thick GaAs layer serving as the cap layer for the FET and the subcollector layer for the HBT; and producing a second set of epitaxial layers for fabricating the HBT.
US07718476B2
A method of fabricating a display apparatus includes depositing a first layer on a substrate while a mask is disposed at a first distance from the substrate, and forming a second layer on the substrate while the mask is disposed at a second distance larger than the first distance from the substrate after forming the first layer. Thus, the present invention provides a method of fabricating a display apparatus, in which a single mask is used in forming an electron injection layer and a common electrode.
US07718474B2
A semiconductor device includes a pair of select gate structures which are opposed to each other and which are formed in a select transistor formation area, each of the select gate structures including a gate insulating film formed on a semiconductor substrate and a gate electrode formed on the gate insulating film, and a pair of memory cell gate structure groups which are formed in a pair of memory cell formation areas between which the select transistor formation area is interposed and each of which has a plurality of memory cell gate structures arranged at the same pitch, the pair of select gate structures having sides which are opposed to each other, and at least the upper portion of each of the opposed sides of the select gate structures being inclined.
US07718473B2
An HF control bi-directional switch component of the type having its gate referenced to the rear surface formed in the front surface of a peripheral well of the component, including two independent gate regions intended to be respectively connected to terminals of a transformer having a midpoint connected to the rear surface terminal of the component.
US07718472B2
An integrated circuit package-on-package stacking method includes forming a leadframe interposer including: forming a leadframe having a lead; forming a molded base only supporting the lead; and singulating the leadframe interposer from the leadframe.
US07718468B2
A method includes (a) preparing a substrate, and (b) growing a ZnO-containing compound semiconductor layer above the substrate by supplying at the same time at least Zn and O as source gases and S as a surfactant.
US07718458B2
A method and resulting device for reducing an electrical field at an isolation gap in a capacitive actuator includes providing a bottom electrode layer and forming a pattern in the bottom electrode layer having an isolation gap between center and outer electrode components of the patterned electrode. A spacing material is deposited in the isolation gap, the spacing material having a greater height than a remainder of the patterned electrode, and a sacrificial material is deposited conformably on a surface of the patterned electrode and spacing material. The method also includes applying a deformable electrode to a surface of the sacrificial material, whereby removal of the sacrificial and spacing materials results in a greater spacing between the deformable electrode and the electrode layer at a region of the isolation gap than over a remainder of the spacing between the patterned electrode layer and deformable surface.
US07718457B2
A method of producing a MEMS device provides an apparatus having structure on a first layer that is proximate to a substrate. The apparatus has a space proximate to the structure. The method adds doped material to the space. The doped material dopes at least a portion of the first layer.
US07718456B2
A package for housing a light-emitting element wherein a via hole for wiring provided so as to pass through an insulating substrate is arranged in such a manner that it is positioned under a reflector frame; a method for manufacturing the above package for housing a light-emitting element which comprises the steps of separately providing a green sheet for the substrate and a green sheet for the frame, causing a paste containing a ceramic powder to be present between the two green sheets to bind them, and subjecting them to degreasing and sintering, to thereby integrate them.
US07718429B2
A method of efficiently and conveniently inducing differentiation from bone marrow stromal cells to skeletal muscle cells, which comprises the steps of: (a) the step of adding one or more kinds of substances selected from the group consisting of a cyclic AMP increasing agent, a cAMP analogue, and a cell differentiation stimulating factor to a culture of bone marrow stromal cells, wherein said bone marrow stromal cells are not treated with a demethylating agent, and culturing the cells; (b) the step of introducing a Notch gene and/or a Notch signaling related gene into the cells obtained in the step (a), and culturing the cells to obtain a culture of myoblasts, provided that said culture does not contain the cells introduced with the gene and non-introduced cells; and (c) the step of adding a Notch ligand to the culture of myoblasts obtained in the step (b), and culturing the cells.
US07718418B2
Systems, methods, compositions and apparatus relating to genome selection are disclosed.
US07718408B2
The present application provides a method of reducing and/or removing diglyceride from an edible oil, comprising admixing an edible oil with an acyl acceptor substrate and a diglyceride: glycerol acyltransferase, wherein the diglyceride:glycerol acyltransferase is characterized as an enzyme which in an edible oil is capable of transferring an acyl group from a diglyceride to glycerol. The diglyceride:glycerol acyltransferase can comprise the amino acid sequence motif GDSX. The present invention also relates to the use of a diglyceride:glycerol acyltransferase in the manufacture of an edible oil, for reducing and/or removing diglyceride from said edible oil and to the use of said enzyme in the manufacture of a foodstuff comprising an edible oil for improving the crystallization properties of said foodstuff.
US07718407B2
A process for the preparation of vitamin K2 (MK-7) comprising the culture of Bacillus subtilis mutant strain GN13/72-DSM 17766 deposited on Dec. 5, 2005 at the DSMZ.
US07718403B2
The present invention regards a variety of methods and compositions for whole genome amplification and whole transcriptome amplification. In a particular aspect of the present invention, there is a method of amplifying a genome comprising a library generation step followed by a library amplification step. In specific embodiments, the library generating step utilizes specific primer mixtures and a DNA polymerase, wherein the specific primer mixtures are designed to eliminate ability to self-hybridize and/or hybridize to other primers within a mixture but efficiently and frequently prime nucleic acid templates.
US07718394B2
Encephalotoxin produced by activated mononuclear phagocytes is present in individuals having neurological disease including neurodegenerative and neuro-inflammatory diseases, such as Alzheimer's disease (AD), HIV-1-associated dementia (HAD), Creutzfeldt-Jakob disease, Mild Cognitive Impairment, prion disease, minor cognitive/motor dysfunction, acute stroke, acute trauma, or neuro-AIDS. Biochemical detection of encephalotoxin according to the methods of the invention will allow diagnosis of neurological disease in early, presymptomatic stages, thereby allowing early intervention in disease progression as well as identification of subjects or populations at risk for developing neurodegenerative disease. The methods of the invention also provide a mechanism for monitoring progression and treatment of neurological disease.
US07718389B2
The present invention relates to a stabilization composition of coelenterazine or an analog thereof, a kit, a method for measuring a coelenterazine-based biological luminescence, containing coelenterazine or the analog thereof and an antioxidant.
US07718384B2
The present invention discloses a method using human soluble ErbB3, for example p85-sErbB3, as a negative regulator of heregulin-stimulated ErbB2, ErbB3, and ErbB4 activation. The present invention also discloses p85-sErbB3 binding to heregulin with an affinity comparable to that of full-length ErbB3, and competitively inhibiting high affinity heregulin binding to ErbB2/ErbB3 heterodimers on the cell surface of breast carcinoma cells. The present invention also uses p85-sErbB3 to inhibit heregulin-induced phosphorylation of ErbB2, ErbB3, and ErbB4 in cells, as a negative regulator of heregulin-stimulated signal transduction, and as a block for cell growth. The present invention is also directed to nucleic acids and expression vectors encoding p85-sErbB3, host cells harboring such expression vectors, and methods of producing the protein. The present invention discloses a method of therapeutically treating human malignancies associated with heregulin-mediated cell growth such as breast and prostate cancer.
US07718383B2
The present invention relates to the discovery of a specific human taste receptor in the T2R taste receptor family, hT2R64 that responds to particular bitter compounds The present invention further relates to the use of this receptor in assays for identifying ligands that modulate the activation of this taste receptor. These compounds may be used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste. A preferred embodiment is the use of the identified compounds as additives in foods, beverages and medicinals for blocking bitter taste.
US07718381B2
The present invention concerns a method of identifying a cell colony which expresses a soluble variant of a target protein which method comprises (a) subjecting the cell colony to conditions which are capable of causing lysis thereof; (b) filtering the lysate through a filter having pores which allow only soluble proteins to pass through the filter; and (c) detecting target protein which has passed through the filter where the target is not detected an the basis of its own enzymatic activity. The invention further covers the identification of a cell colony expressing a soluble variant of a membrane protein using steps (a) and (b) of the method above. A kit for use in the methods is also covered by the invention.
US07718376B2
The present invention relates to the identification of a specific population of cell types, in particular somatic stem cells including haematopoietic stem cells, mesenchymal stem cells and keratinocyte stem cells. The invention also provides for methods of isolation and uses of the stem cells. Derived from the methods of the present invention, there is provided a method of identifying a stem cell comprising the steps of: obtaining a cell sample including stem cells; detecting the presence of angiotensin converting enzyme (ACE) or a fragment thereof on a cell; and identifying the stem cells having ACE or a fragment thereof.
US07718368B2
The invention generally features the use of Yaba monkey tumor virus nucleic acid molecules and polypeptides for the treatment or prevention of immunoinflammatory disorders.
US07718367B2
Methods and kits are provided for diagnosing, monitoring, or predicting preeclaimpsia in a pregnant woman, trisomy 18 and trisomy 21 in a fetus, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more RNA species derived from a set of genetic loci and comparing the amount of the RNA species with a standard control.
US07718359B2
The invention relates to a method for inducing protection against the 4 serotypes of dengue fever in a patient, comprising: (a) the administration of a monovalent vaccine comprising a vaccinal virus of a first serotype of dengue fever, and (b) the administration of a tetravalent vaccine comprising vaccinal viruses of the four serotypes of dengue fever, in which administration (b) is made between at least 30 days and not more than 12 months following the first administration (a).
US07718352B2
There is provided a process for producing an EL element by photolithography, which process can produce an EL element having improved luminescence efficiency. The production process comprises the steps of removing a photoresist from photoresist layer-covered parts of an electroluminescent layer and cleaning the surface of the electroluminescent layer parts from which the photoresist has been removed.
US07718351B2
Methods and apparatuses involving biocompatible structures for tissue engineering and organ replacement and, more specifically, biocompatible structures formed by three-dimensional fabrication, are described. In some embodiments, the biocompatible structures are scaffolds for cells that can be used as tissue engineering templates and/or as artificial organs. The structures may be three-dimensional and can mimic the shapes and dimensions of tissues and/or organs, including the microarchitecture and porosities of the tissues and organs. Pores in the structure may allow delivery of molecules across the structure, and may facilitate cell migration and/or generation of connective tissue between the structure and its host environment. Structures of the invention can be implanted into a mammal and/or may be used ex vivo as bioartificial assist devices.
US07718349B2
The invention relates to a method for producing submicron structures using a shadow mask, whereby a material charge and/or energy charge occurs through the openings of the shadow mask. The method comprises the following steps: a film which is used as a shadow mask and which is made of a masking material is applied to the substrate, tears are produced in the film, the tears extending until the substrate, edge areas of the film arranged on the tears are detached thereby exposing the substrate and the material or the energy is applied to the substrate by the tears, also above the exposed edge area of the shadow mask film.
US07718336B2
A photoconductor containing a supporting substrate, a photogenerating layer; and at least one charge transport layer where the photogenerating layer contains a photogenerating pigment and a chelating additive or agent of, for example, a β-diketone, a ketoester, a hydroxyl carboxylic acid, a hydroxyl carboxylic acid ester, a keto alcohol, or an amino alcohol.
US07718335B2
An image bearing member is provided, including a substrate and a surface layer formed by optically curing at least a radical polymerizable compound with a charge transport structure and a radical polymerizable monomer without a charge transport structure, wherein the transmission factor of the surface layer for light having a wavelength by 25 nm longer than an absorption end wavelength of photo-absorption spectrum of the surface layer prior to optical curing is not less than 65%.
US07718330B2
An image forming method characterized in that a plurality of toner images which differ in color is formed as superposed; a plurality of the superposed toner images is simultaneously transferred onto a sheet of recording paper; the turbidity of toners of each color which form a plurality of the toner images is less than 60; and the maximum turbidity difference among said toners of each color is 5-45.
US07718329B2
Provided is a method of fabricating a liquid crystal display device. The method includes fabricating a liquid crystal panel divided into transmission and non-transmission regions, and including an upper substrate and a lower substrate, which are spaced apart from and opposite to each other, and a liquid crystal layer filled between the substrates, wherein the lower substrate has a plurality of thin film transistors; depositing a transparent conductive layer having a certain thickness on the upper substrate exposed to the exterior of the liquid crystal panel; and performing an etching process for removing the entire transparent conductive layer and a portion of the upper substrate to form irregular prominences and depressions on a surface of the upper substrate exposed to the exterior. Therefore, it is possible to improve readability and contrast ratio by diffusely reflecting external light and scattering internal light.
US07718326B2
This invention addresses the scalability problem of periodic “nanostructured” surface treatments such as those formed by interference lithography. A novel but simple method is described that achieves seamless stitching of nanostructure surface textures at the pattern exposure level. The described tiling approach will enable scaling up of coherent nanostructured surfaces to arbitrary area sizes. Such a large form factor nanotechnology will be essential for fabricating large aperture, coherent diffractive elements. Other applications include high performance, antiglare/antireflection and smudge resistant Motheye treatments for display products such as PDA's, laptop computers, large screen TV's, cockpit canopies, instrument panels, missile and targeting domes, and, more recently, “negative-index” surfaces. Although ideal for seamless stitching of nanometer scale patterns, the technology is broadly applicable to any situation where an arbitrarily large area needs to be seamlessly tiled with a smaller base pattern that has periodic overlap able boundaries.
US07718325B2
An image forming medium includes a substrate and an imaging layer coated on or impregnated into said substrate, where the imaging layer includes as a photochromic material a spiropyran compound having a conjugated pathway, dispersed in a polymeric binder, wherein the photochromic material exhibits a reversible transition between a colorless state and a colored state in response to heat and light.
US07718322B2
Disclosed in an electrolyte for a rechargeable lithium battery, including a mixture of organic solvents including a cyclic solvent and a nitrile-based solvent represented by formula 1 and a lithium salt.
US07718320B2
A family of Li-ion battery cathode materials and methods of synthesizing the materials. The cathode material is a defective crystalline lithium transition metal phosphate of a specific chemical form. The material can be synthesized in air, eliminating the need for a furnace having an inert gas atmosphere. Excellent cycling behavior and charge/discharge rate capabilities are observed in batteries utilizing the cathode materials.
US07718319B2
The present invention includes compositions and methods of making cation-substituted and fluorine-substituted spinel cathode compositions by firing a LiMn2−y−zLiyMzO4 oxide with NH4HF2 at low temperatures of between about 300 and 700° C. for 2 to 8 hours and a η of more than 0 and less than about 0.50, mixed two-phase compositions consisting of a spinel cathode and a layered oxide cathode, and coupling them with unmodified or surface modified graphite anodes in lithium ion cells.
US07718314B2
A cathode material capable of improving capacity and superior low temperature characteristics, and a battery using the cathode material are provided. A cathode and an anode are layered with an electrolyte layer and a separator in between. The cathode contains a complex oxide containing lithium, manganese, nickel, and cobalt; a complex oxide containing lithium and at least one of nickel and cobalt; and a complex oxide containing lithium and manganese and having a spinel structure or a phosphorus oxide containing lithium and iron at a given ratio.
US07718310B1
An electrochemical cell is described. The cell comprises a cathode material contacted to a perforated current collector having a portion left uncovered and an anode material contacted to an anode current collector. The anode comprises first and second strips positioned on opposite sides of the cathode, which is also in the form of a strip, but one that is much longer than each of the anode strips. Proximal ends of the anode strips reside adjacent to where the cathode is secured to a terminal pin/sleeve assembly. Distal ends of the anode strips are adjacent to the opposed ends of the cathode strip. A separator sheet segregating the anode from direct contact with the cathode provides an upper portion at least partially sealed to a lower portion along an aligned peripheral edge and through the uncovered perforations of the cathode current collector to lock the cathode in position. The anode and cathode are then wound into a galaxy electrode assembly housed in a cylindrical casing and activated with an electrolyte.
US07718301B2
A fuel supply apparatus for supplying fuel to a fuel cell has a fuel supply unit and a water suction unit. When the fuel cell is mounted onto the fuel supply apparatus, the apparatus supplies fuel to the fuel cell and removes the water inside the fuel cell by suction.
US07718300B2
The present invention relates to frame elements for monopolar fuel cell stacks, permitting a simplified electrical wiring and/or a simplified and improved assembly of monopolar fuel cell stacks. They permit a significant miniaturization of monopolar arrangements.
US07718298B2
A bipolar plate for a fuel cell is provided that includes a flowfield having an active surface with an inlet region and an outlet region. The active surface of the flowfield is in communication with the inlet region and the outlet region and has at least one flow channel formed therein. The at least one flow channel further has a cross-sectional area at the outlet region that is less than a cross-sectional area at the inlet region. In particular embodiments, the at least one flow channel is bifurcated. A fuel cell stack including a fuel cell and the bipolar plate is also provided.
US07718288B2
A fuel cell system that employs a diode electrically coupled between bipolar plates in a fuel cell of a fuel cell stack for preventing the fuel cell between the plates from reversing its polarity. The diode is a thin-sheet p-n diode including doped semiconductor layers and has a thickness relative to the thickness of the MEA in the fuel cell so that the overall stack thickness does not increase. When the fuel cell is operating properly the diode does not conduct and all of the current through the fuel cell goes through the MEA. If the electric load on the stack increases to a level beyond the capability of the fuel cell, where the potential across the fuel cell goes significantly below zero, the diode will begin to conduct so that any current that cannot travel through the MEA with the cell voltage less than one negative forward diode voltage drop is able to go around the MEA through the diode.
US07718286B2
An abnormality detecting device of a fuel cell system according to the invention includes a hydrogen off-gas circulation passage for making hydrogen off-gas discharged from a fuel cell flow back to an anode; a discharge passage for discharging part of the hydrogen off-gas, which is circulated through the hydrogen off-gas circulation passage, from the hydrogen off-gas circulation passage; a hydrogen discharge valve provided in the discharge passage; abnormality determining means for determining whether an abnormality has occurred in opening/closing of the hydrogen discharge valve and gas state quantity detecting means for detecting a gas state quantity of the hydrogen off-gas, the gas state quantity detecting means being provided in the discharge passage at a position downstream from the hydrogen discharge valve. The abnormality determining means determines whether an abnormality has occurred in opening/closing of the hydrogen discharge valve based on the gas state quantity of the hydrogen off-gas.
US07718284B2
A base insulating layer of an FPC board includes a rectangular first insulating portion and a second insulating portion that outwardly extends from one side of the first insulating portion. A conductor layer is formed on one surface of the base insulating layer. The conductor layer includes a pair of rectangular collector portions and a pair of extraction conductor portions that extend in a long-sized shape from the collector portions. One collector portion is formed in a first region of the first insulating portion of the base insulating layer, and the other collector portion is formed in a second region of the first insulating portion. One extraction conductor portion extends from the one collector portion to the second insulating portion, and the other extraction conductor portion extends from the other collector portion to the second insulating portion.
US07718278B2
Provided is an anthracene derivative compound represented by Formula 1 below and an organic light-emitting device using the same: wherein Ar1, Ar2, R1, R2, R′, m, n, j, k, and X are as defined in the specification. The anthracene derivative compound is advantageously used in the production of an organic light-emitting device with better driving voltage, efficiency, and color purity.
US07718271B2
A laser welding material and laser welding method which can satisfactorily weld resin members of different resin materials that have no or little adhesive property is provided and includes a set of resin materials constituting a first resin member, a second resin member and a third resin member in which the first resin member and the second resin member are different materials and the first resin member does not absorb laser light and which is used for laser-welding the three members by overlapping the third resin member with the first and second resin members and irradiating laser light to the three members from the first resin member side, and a layer welding method.
US07718269B2
Provided is a technology capable of improving the reliability of a semiconductor device using a SiOC film as an interlayer film. In the invention, by forming an interlayer film from a SiOC film having a Si—CH3 bond/Si—O bond ratio less than 2.50% or having a strength ratio determined by the FT-IR of a Si—OH bond to a SiO—O bond exceeding 0.0007, a strength ratio of a SiH bond to a SiO—O bond at a wavelength of 2230 cm−1 exceeding 0.0050 and a strength ratio of a Si—H bond to a SiO—O bond at a wavelength of 2170 cm−1 exceeding 0.0067, the interlayer film has a relative dielectric constant of to 3 or less, and owing to suppression of lowering in hardness or elastic modulus, has improved mechanical strength.
US07718265B2
Provided is a release sheet which is non-silicone-based and has a good releasability from a layer of a pressure sensitive adhesive and which has a stable antistatic property without being influenced by the air environment and is free of bleeding out of ionic substances derived from an antistatic agent. The release sheet is prepared by providing an undercoat layer containing a polyurethane-based resin and 0.1 to 45% by mass of a lithium salt-based antistatic agent and a layer of a rubber-based release agent formed by coating and drying a liquid containing a release agent in order on a substrate.
US07718263B2
An aqueous primer composition of the present invention includes a water-dispersible polyisocyanate (A) and an acrylic resin water dispersion (B), wherein a polystyrene equivalent weight average molecular weight, determined using gel permeation chromatography, of an acrylic resin in the acrylic resin water dispersion (B) is 350,000 or more, and a glass transition temperature, determined by using a differential scanning calorimeter, of the acrylic resin is 15° C. to 130° C., and a weight ratio between the water-dispersible polyisocyanate (A) and the acrylic resin water dispersion (B) is (A):(B)=70:30 to 50:50.
US07718262B2
Microspheres, populations of microspheres, and methods for forming microspheres are provided. One microsphere configured to exhibit fluorescent and magnetic properties includes a core microsphere and a magnetic material coupled to a surface of the core microsphere. About 50% or less of the surface of the core microsphere is covered by the magnetic material. The microsphere also includes a polymer layer surrounding the magnetic material and the core microsphere. One population of microspheres configured to exhibit fluorescent and magnetic properties includes two or more subsets of microspheres. The two or more subsets of microspheres are configured to exhibit different fluorescent and/or magnetic properties. Individual microspheres in the two or more subsets are configured as described above.
US07718244B1
A protective mat assembly for a boxing ring includes a substantially trapezoidal base mat having multiple strips of hook and loop fasteners on the upper surface thereof. A similarly-shaped absorbent foam pad includes a plurality of mating hook and loop fastener strips on a lower surface to engage those of the base mat. The absorbent pad includes foot indentions for receiving a boxer's feet, and openings for receiving the legs of a boxer's stool. Accordingly, when a fighter sits on the stool between rounds, the underlying absorbent pad collects any fluids that would otherwise fall onto the ring surface.
US07718240B2
Elastomeric film-like products such as natural latex gloves are coated with novel lubricity compositions and compositions which protect the skin of the wearer from certain undesirable medical conditions. In powder-coated gloves, the coating composition comprises rice starch, and optionally USP-grade colloidal oatmeal in pharmaceutically accepted concentration. In powder-free gloves, the coating composition comprises colloidal oatmeal enhanced water or beta glucan solution, optionally in combination with one or more other starch components. Colloidal oatmeal enhanced water, and methods of making the colloidal oatmeal enhanced water are also disclosed. In addition, beta glucan solution, and methods of making the beta glucan solution are also disclosed. A liquid referred to herein as Polycoat may also be made by mixing colloidal oatmeal enhanced water with beta glucan solution, and the resulting liquid may be applied to elastomeric articles such as gloves.
US07718234B2
A liquid crystal display is provided which is capable of reducing the occurrence of defective display due to variations in the initial alignment direction of a liquid crystal alignment control film in a liquid crystal display of an IPS scheme, realizing the stable liquid crystal alignment, providing excellent mass productivity, and having high image quality with a higher contrast ratio. The liquid crystal display has a liquid crystal layer disposed between a pair of substrates, at least one of the substrates being transparent, and an alignment control film formed between the liquid crystal layer and the substrate. At least one of the alignment control films comprises photoreactive polyimide and/or polyamic acid provided with an alignment control ability by irradiation of substantially linearly polarized light.
US07718223B1
A method for controlling density or tower height of carbon nanotube (CNT) arrays grown in spaced apart first and second regions on a substrate. CNTs having a first density range (or first tower height range) are grown in the first region using a first source temperature range for growth. Subsequently or simultaneously, CNTs having a second density range (or second tower height range), having an average density (or average tower height) in the second region different from the average density (or average tower height) for the first region, are grown in the second region, using supplemental localized heating for the second region. Applications for thermal dissipation and/or dissipation of electrical charge or voltage in an electronic device are discussed.
US07718218B2
A thin-film magnetic head has a laminated construction comprising a main pole layer having a magnetic pole tip on a side of the medium-opposing surface opposing a recording medium, a write shield layer opposing the magnetic pole tip forming a recording gap layer, on the side of the medium-opposing surface, and a thin-film coil wound around at least a portion of the write shield layer. The thin-film magnetic head has an upper yoke pole layer having a larger size than the portion of the main pole layer which is more distant from the medium-opposing surface than the recording gap layer, wherein the upper yoke pole layer is joined to the side of the main pole layer which is near the thin-film coil.
US07718217B2
An object of the present invention is to provide a method and an apparatus for marking an electric wire at a low cost. An apparatus 1 for marking an electric wire forms a band mark 21 on a part of an outer face 5a of the electric wire 3. The band mark 21 is formed along the entire circumference of the part of the outer face 5a of the electric wire 3. The marking apparatus 1 tightens the electric wire 3 in a state where a tensile force is applied in a longitudinal direction. The marking apparatus 1 includes a nozzle 35 for injecting coloring agent toward an uppermost position 10 of the outer face 5a of the electric wire 3. The nozzle 35 has an open end 42 which is opposed to the electric wire 3 and capable of passing the coloring agent. A straight line L extending between a center C1 of the open end 42 and a center C2 of the electric wire 3 lies along a vertical direction.
US07718215B2
An apparatus for forming alignment layer includes a printing stage for supporting a substrate thereon, at least one inkjet head having at least one spray hole above the printing stage, the spray hole spraying an alignment material onto the substrate, a head support supporting the inkjet head, a pitch measuring unit adjacent to the inkjet head, and a display unit displaying measured results provided by the pitch measuring unit.
US07718210B2
The present invention provides a novel cellular solid structure which can be used to structure an oil-water mixture into a semi-solid state. The invention is particularly useful in the manufacture of food products, such as margarine-like spreads, other spreads and dips and dairy-like products such as whipped toppings and creamy fillings.
US07718209B2
A low common salt soy sauce, which has good flavor, significantly suppresses elevation of blood pressure, prevents cardiac hypertrophy, and is also available as special nutritious food, is obtained. 1.0% to 10.0% by weight of potassium chloride and 0.1% to 5.0% by weight of γ-aminobutyric acid are added to a reduced common salt soy sauce, so as to obtain a low common salt soy sauce of issue. Otherwise, a KCl-containing low common slat soy sauce is obtained by: (1) a common production method of soy sauce, in which a mixed solution consisting of KCl and common salt is used as mother water; (2) a method of subjecting a soy sauce obtained using saline solution as mother water to electrodialysis, a membrane treatment, or the like, so as to eliminate common salt from the above soy sauce, and then adding KCl thereto; or other methods. Thereafter, γ-aminobutyric acid is added to the above KCl-containing low common salt soy sauce, so as to obtain a low common salt soy sauce comprising 0% to 10% by weight of common salt, 1.0% to 10.0% by weight of potassium chloride, and 0.1% to 5.0% by weight of γ-aminobutyric acid.
US07718208B2
Disclosed are improved packages and methods for packaging meat, fish, poultry, vegetables or other food products. A package of the present invention is a vacuum skin package comprising a multilayer film comprising at least one layer of an organic acid modified ionomer blend and at least one layer of an ethylene-containing polymer, such as an ethylene/vinyl acetate copolymer, wherein the film has specific gas permeability requirements.
US07718204B2
There is provided use of a conversion agent to prepare from a food material a foodstuff comprising at least one functional ingredient, wherein the at least one functional ingredient has been generated from at least one constituent of the food material by the conversion agent.
US07718196B2
Methods for generating highly enriched Th1/Tc1 and Th2/Tc2 functions are described. In particular, the generation of these functions are attained by the addition of an immune suppression drug, rapamycin or a rapamycin derivative compound. In addition to enhanced purity of T cell function, the T cells generated in rapamycin also express molecules that improve immune T cell function such as CD28 and CD62L. Such rapamycin generated functional T cell subsets may have application in the prevention or treatment of GVHD after allogeneic hematopoietic stem cell transplantation, the treatment of autoimmunity, or the therapy of infection or cancer.
US07718191B2
The invention relates to the novel use of a pharmaceutical product which combines domperidone and pseudoephedrine sulphate substances and which can be used to reduce or stop moderate or severe snoring.
US07718190B2
Certain diacylglycerol-polyethyleneglycol (DAG-PEG) lipids are especially useful for forming thermodynamically stable liposomes. Such liposomes are useful for a variety of purposes, including the delivery of therapeutic agents.
US07718189B2
Provided are lipid antiinfective formulations substantially free of anionic lipids with a lipid to antiinfective ratio is about 1:1 to about 4:1, and a mean average diameter of less than about 1 μm. Also provided is a method of preparing a lipid antiinfective formulation comprising an infusion process. Also provided are lipid antiinfective formulations wherein the lipid to drug ratio is about 1:1 or less, about 0.75:1 or less, or about 0.50:1 or less prepared by an in line fusion process. The present invention also relates to a method of treating a patient with a pulmonary infection comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention. The present invention also relates to a method of treating a patient for cystic fibrosis comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention.
US07718184B2
Coated particles of metal (such as calcium) silicate that exhibit excellent odor neutralization and sebum absorption properties when present within certain cosmetic and/or personal care formulations and suspensions are provided. Uncoated calcium silicate exhibits a high pH level that may have a deleterious effect upon such cosmetic and/or personal care compositions, thereby rendering the overall composition ineffective for its intended purpose, particularly if the calcium silicate is present in its usual state at high loading levels. Alternatively, if certain materials present within personal care compositions exhibit a sufficiently low pH level, the effectiveness of such calcium silicates may be compromised as well. Such novel coated/treated calcium silicates thus permit high loadings of this beneficial odor neutralizing/sebum absorbing additive within cosmetic and/or personal care formulations without causing any appreciable instability issues or viscosity modification concerns or allow for coexistence with such low pH materials without any appreciable reduction in performance capabilities of the calcium silicates themselves. Certain personal care compositions comprising these novel coated calcium silicate particulates are encompassed within this invention as well.
US07718183B2
The invention relates to three isolated DNA molecules that encode for proteins, BigL1, BigL2 and BigL3, in the Leptospira sp bacterium which have repetitive Bacterial-Ig-like (Big) domains and their use in diagnostic, therapeutic and vaccine applications. According to the present invention, the isolated molecules encoding for BigL1, BigL2 and BigL3 proteins are used for the diagnosis and prevention of infection with Leptospira species that are capable of producing disease in humans and other mammals, including those of veterinary importance.
US07718171B2
Use of a composition obtainable by a process comprising fermenting a food material, comprising animal milk or vegetable proteins, with a lactic acid bacterium to obtain a fermented food material which comprises active components with heart rate reducing properties for the manufacture of a product for reducing the heart rate and/or the fluctuations in the heart rate of a mammalian.
US07718168B2
The present invention provides a medical implant material comprising mammalian transglutaminase and a polymer, wherein the transglutaminase is provided in the absence of free divalent metal ions and wherein the polymer is associated with the transglutaminase binding protein. Preferably, the transglutaminase is a tissue transglutaminase, which is coated on, impregnated into or covalently linked to the polymer. The polymer may be naturally occuring or synthetic, and may be biodegradable or non-biodegradable. The medical implant material may further comprise a reinforcing agent and/or one or more additional polymers. The invention further provides the use of a mammalian transglutaminase in a method for improving the biocompatibility of a medical implant material, the method comprising the steps of (i) providing a medical implant material comprising a polymer associated with a binding protein for binding the transglutaminase, and (ii) treating said material with a mammalian transglutaminase.
US07718160B2
The invention, in one aspect, relates to radiolabeled compounds. The invention also relates to radiolabeled liposomes and methods of making and using thereof. The invention also relates to kits for preparing radiolabeled liposomes.
US07718159B2
The invention describes a process for co-production of electricity and a hydrogen-rich gas by steam reforming of a hydrocarbon fraction with input of calories by combustion with the hydrogen that is produced inside the steam reforming reactor-exchanger.
US07718157B1
Targeted lipids and lipid particles are described which are assemblies of multipolar lipids, targeting molecules such as antibodies and polyanions. The lipids are of particular use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo.
US07718156B2
Carbon nanostructures are formed from a carbon precursor and catalytic templating nanoparticles. Methods for manufacturing carbon nanostructures generally include (1) forming a precursor mixture that includes a carbon precursor and a plurality of catalytic templating particles, (2) carbonizing the precursor mixture to form an intermediate carbon material including carbon nanostructures, amorphous carbon, and catalytic metal, (3) purifying the intermediate carbon material by removing at least a portion of the amorphous carbon and optionally at least a portion of the catalytic metal, and (4) heat treating the purified intermediate carbon material and/or treating the purified intermediate carbon material with a base to remove functional groups on the surface thereof. The removal of functional groups increases the graphitic content of the carbon nanomaterial and decreases its hydrophilicity.
US07718151B1
An improved process for deacidizing a gaseous mixture using phase enhanced gas-liquid absorption is described. The process utilizes a multiphasic absorbent that absorbs an acid gas at increased rate and leads to reduced overall energy costs for the deacidizing operation.
US07718145B2
A polyisocyanate production system is provided that can stably produce chlorine from hydrogen chloride produced secondarily while reacting stably between carbonyl chloride and polyamine and can perform an effective treatment of the hydrochloric gas produced secondarily. A hydrochloric gas control unit 32 controls a flow-rate control valve 23 to keep constant an amount of hydrogen chloride supplied from a hydrogen chloride purifying tank 4 to a hydrogen chloride oxidation reactor 6 via a second hydrochloric-gas connection line 11 to be constant, and also controls a pressure control valve 22 based on an inner pressure of the hydrogen chloride purifying tank 4 input from a pressure sensor 25 to discharge the hydrochloric gas from the hydrogen chloride purifying tank 4 to the hydrogen chloride absorbing column 5 via a first hydrochloric-gas connection line 10, so as to keep an inner pressure of the hydrogen chloride purifying tank 4 to be constant.
US07718142B2
An apparatus configured for treating sulfur at an elevated pressure. Embodiments of the apparatus comprises a vessel into which the sulfur is injected and a device for alleviating the pressure of the sulfur.
US07718131B2
Disclosed herein is a holder for biological sample containers such as well plates. The holder comprises a flat vacuum bed surrounded by a seal. A container is placed within the seal and a vacuum is applied, pressing and flattening the lower surface of the sample container against the flat vacuum bed. Samples in all portions of the container may then be imaged without the need to refocus on each portion of the container. For imaging, a sample in a well can be illuminated by a beam of light arranged so that a part or all of the sample is illuminated by direct rays that have not passed through the well plate. The beam is redirected to other parts of the well if a single illumination does not cover the whole well, so that the sample to be imaged using a series of partial images.
US07718122B2
This invention relates to particulate forms of carrier materials containing an oxidant, especially hypohalite or hypohalous acid, especially a dry particulate form of dilute or concentrated hypochlorite and hypochlorous acid compositions. The invention also relates to uses for these particles, such as for generating hypochlorous acid vapor to control the growth of mold or bacteria, to deactivate allergens and allergen causing agents, and to control odors.
US07718120B2
A system and method are provided for the thermal and non-thermal (oxidation) plasma treatment of medical waste using an electrode-less induction (thermal) and capacitive (non-thermal) plasma torches. The medical waste is pre-treated by liquid nitrogen, crushed and pulverized by LN2 crusher/pulverizer, and conveyed to the nitrogen/water thermal plasma reactor, which converts the powdered medical waste into carbon black and generated gas (resulting from the thermal step) is directed to the Oxygen non-thermal plasma reactor for post-treatment. The system is equipped with an emission control unit, dual frequency pulse RF power supply, and Liquid Nitrogen Generator. The off gas from LN2 crusher (nitrogen) is used for the induction plasma torch and off gas from LN2 generator (oxygen) is used as a plasma gas for the Non-thermal plasma torch.
US07718118B2
The present invention relates to creep-resistant magnesium-based alloys with low susceptibility to hot tearing, and with improved ductility, impact strength and fracture toughness, and corrosion resistance. The alloys contain at least 96 wt % magnesium, 1.5 to 1.9 wt % neodymium, 0.10 to 0.30 wt % yttrium, 0.35 to 0.70 wt % zirconium, 0.05 to 0.35 wt % zinc, 0.01 to 0.10 wt % calcium, 0.01 to 0.15 wt % strontium, and 0.0000 to 0.0005 wt % beryllium, and they are suitable for low pressure and gravity castings. Articles, that are castings of the alloys, are suitable for applications at temperatures as high as 175-250° C.
US07718112B2
Nanometer scale structures, and methods of making the same are disclosed.
US07718106B2
Medical devices including a proximal tubular member, a distal tubular member, and an intermediate tubular member connecting the proximal tubular member to the distal tubular member, and related methods.
US07718105B2
A method for fabricating a product, such as an amimatronic character, with artificial skin. The method includes providing data defining an exterior surface geometry of the product. A base geometry model of the product is generated based on the exterior surface geometry data, which in turn is used to fabricate a prototype of the product. Then, an exterior skin mold is formed using the product prototype mounted on an alignment block. The method includes fabricating an inner support structure based on the base geometry model having an exterior geometry smaller than the 3D base geometry model by the thickness of the exterior skin. The inner support structure is positioned within the mold with the inner support structure mounted upon the alignment block, which is received in the mold. The product is formed by pouring material for an exterior skin layer into the mold and over the inner support structure.
US07718103B2
A process for forming flexible noise attenuating cutting line for use in rotary vegetation trimmers formed of at least two monofilament polymer strands bonded together in a twisted disposition or a single strand twisted about its central axis in which the strand or strands are extruded in a molten disposition through a single die that is rotated during the extruding step either to twist the two strands together about a central longitudinal axis or a single strand about its own longitudinal axis such that upon cooling, stretching and heating, a flexible noise attenuating line is created in a continuous online process.
US07718101B2
A process for producing a friction material based on a sheet-like carbon fiber woven fabric for wet-friction elements, such as clutch linings or synchronizing ring linings. The woven fabric of carbon fibers is impregnated with a binder, in particular with a resin, to form a binder-impregnated fiber material. The prepreg is cured for a curing period under a curing temperature which is elevated with respect to the ambient temperature and is pressed mechanically on its surfaces with a pressing mold before the start and/or at least during part of the curing period.
US07718094B2
A method for the formation of metallic nanoparticles, such as gold and silver nanoparticles, which involves, combining in a single solution, solvent, metal ions and copolymers under conditions such that metal nanoparticles are formed. The copolymers have both reducing components and stabilizing components. The method can be used to form metal nanoparticles having a desired shape and size.
US07718082B2
The invention concerns a powder metallurgical composition containing, preferably a coarse, soft magnetic iron or iron-based powder, wherein the particles are surrounded by an insulating inorganic coating and as lubricant at least one non-drying oil or liquid having a crystalline melting point below 25° C., a viscosity (η) at 40° C. above 15 mPas and wherein said viscosity is temperature dependent according to the following formula: 10 log η=k/T+C wherein the slope k is above 800 T is in Kelvin and C is a constant in an amount between 0.05 and 0.4% by weight of the composition.
US07718080B2
Methods and devices for selective etching in a semiconductor process are shown. Chemical species generated in a reaction chamber provide both a selective etching function and concurrently form a protective coating on other regions. An electron beam provides activation to selective chemical species. In one example, reactive species are generated from a plasma source to provide an increased reactive species density. Addition of other gasses to the system can provide functions such as controlling a chemistry in a protective layer during a processing operation. In one example an electron beam array such as a carbon nanotube array is used to selectively expose a surface during a processing operation.
US07718078B2
A manufacturing method of a circuit board is provided. Firstly, a substrate board having a plurality of through holes is provided. Next, a first metal layer is electro-less plated on the surface of the substrate board and the surface of the through holes. Then, a second metal layer is plated on the first metal layer. After that, the second metal layer and the first metal layer are patterned to form a patterned circuit layer. Lastly, a third metal layer is plated on the patterned circuit layer.
US07718072B2
Magnetic handling structure (1a) comprising a retractable magnet (4) and a probe (3) for the manipulation of magnetic particles in biological samples and methods of handling magnetic particles in biological samples.
US07718069B2
The invention relates to a method and system for treating an aqueous liquid containing dissolved minerals and dissolved hydrocarbons. Method steps and apparatus for treating a waste water feed stream are disclosed which utilize a warm lime softening system in fluid communication with the waste water feed stream, wherein sludge from the warm lime softening system is recycled to improve lime utilization and enhance silica and boron removal without the addition of an external source of magnesium. In addition, a microfiltration system and/or an air stripper system may be used in fluid communication with at least one reverse osmosis system to produce a treatment water that meets state and federal guidelines for surface discharge.
US07718059B2
An apparatus for producing magnetized water. The apparatus comprises a plurality of magnet bars arranged in a radial manner, in which each magnet bar is structured such that a plurality of neodymium based permanent magnets is stacked in a stainless steel pipe in a manner such that like poles of the permanent magnets face each other. Thanks to this structure, the apparatus has a large contact area between the magnetic field and water flowing through the apparatus, thereby activating water by changing the structure of water. In more detail, the apparatus comprises a magnet bunch including a plurality of fixed magnet bars, a plurality of standard magnet bars, an upper plate disposed on upper ends of the fixed and standard magnet bars, a lower plate disposed on lower ends of the fixed and standard magnet bars, and a spacing plate disposed between the upper and lower plates; a housing having a cylindrical main body for enclosing the magnet bunch therein, an opening in an upper end portion thereof, and a lower part having a funnel shape and a liquid passage; and a cover 50 for covering the opening of the housing, the cover being coupled to the housing in a detachable manner and having a funnel shape and a liquid passage.
US07718039B2
A process for reactive distillation wherein a carboxylic acid is reacted in a reaction section of a reactive distillation column with an alcohol under esterifying conditions in the presence of a catalyst to form an ester, wherein a first supply stream comprising the carboxylic acid, a second supply stream comprising the alcohol and a third supply stream comprising an inert entrainer are supplied to the reactive distillation column, wherein the first supply stream is supplied to the column at a first entry level located just above or at the top of the reaction section, the second supply stream is supplied to the column at a second entry level located in or just below the reaction section and below the first entry level, and the third supply stream is supplied to the column at a third entry level located in or below the reaction section and not above the second entry level and wherein a bottom stream comprising the ester formed and unreacted carboxylic acid is obtained and a top stream comprising unreacted alcohol, water and entrainer is obtained.
US07718035B2
An improved creping adhesive is prepared by first reacting a dibasic carboxylic acid, or its ester, half-ester, or anhydride derivative, with a polyalkylene polyamine, preferably in aqueous solution, under conditions suitable to produce a water soluble polyamide. The water-soluble polyamide is then reacted with an epihalohydrin until substantially fully cross-linked, and stabilized by acidification with phosphoric acid at the end of the polymerization reaction to form a water-soluble poly(aminoamide)-epihalohydrin creping adhesive that is re-wetable and facilitates water spray removal of buildup so as to lengthen the life of the creping blades, with attendant significant decrease in downtime and maintenance.
US07718034B2
A refiner steam separation system according to the present invention includes a blowline for transporting a mixture of fiber material from a refiner to an inlet of a steam separator. Waste steam is discharged from the separator through a waste steam outlet. Cleaned fiber material is discharged from the separator through an exit, which prevents a substantial portion of the waste steam from passing through the exit. A relay pipe communicates with the exit and a dryer duct, and transports cleaned fiber material therebetween. A resin input communicates with the relay pipe, and supplies resin therein. The resin is mixed with the cleaned fiber material prior to the cleaned fiber material being dried in the dryer duct. The present invention is also directed to a method of reducing VOC emissions generated during refining cellulosic fibrous material.
US07718028B2
A process for forming fluid filled units is disclosed. In the process, a web having a series of side connected pouches are fed to an inflation station. The pouches are connected by a line of perforations. First perforations of the line of perforations that extend from an inflation opening of each pouch are shorter than second perforations of the line of perforations that extend from the first perforations toward a side edge of each pouch. The pouches filled with fluid and sealed to form fluid filled units.
US07718016B2
Methods of making multilayered, hydrogen-containing intermetallic structures including at least two adjacent metal layers are disclosed. At least one of the metal layers contains hydrogen, which can be introduced into the metal by plasma hydrogenation. The intermetallic structures can have high hydrogen contents and micrometer-sized and nanometer-sized dimensions.
US07718014B2
The present invention provides a low alloy steel and a weld joint thereof excellent in hydrochloric acid corrosion resistance and sulfuric acid corrosion resistance, said low alloy steel containing, in mass, C: 0.001 to 0.2%, Si: 0.01 to 2.5%, Mn: 0.1 to 2%, Cu: 0.1 to 1%, Mo: 0.001 to 1%, Sb: 0.01 to 0.2%, P: 0.05% or less, and S: 0.05% or less, with the balance consisting of Fe and unavoidable impurities; and the acid corrosion resistance index AI of said low alloy steel being zero or positive. Here, said AI is given by the following expression, AI/10,000=0.0005+0.045×Sb %−C %×Mo %, where % means mass %.
US07718012B2
A method of improving the effectiveness of semiconductor cleaning solvents is provided. Insoluble gas bubbles, typically air, hinder wet chemical cleaning methods. Preferred embodiments include purging a first, insoluble gas from the cleaning system and replacing it with a second, soluble gas. After replacing the first gas with the second gas, the wafer is rinsed in the cleaning solvent. Any gas bubbles trapped within narrow, recessed features during cleaning rapidly dissolve due to the second gas's solubility. Temperature adjustments during the process may further enhance cleaning.
US07718007B2
A substrate supporting member, and a substrate processing apparatus including the substrate supporting member are provided. The substrate supporting member for mounting and supporting a substrate on a substrate supporting surface thereof, and controlling a temperature of the substrate by thermal transfer between the substrate and the substrate supporting surface, wherein the substrate supporting surface is smaller than the substrate, and includes a central region, an intermediate region, and a peripheral region. A thermal conductivity between the substrate and the peripheral region is greater than that between the substrate and the central region which is greater than that between the substrate and the intermediate region located between the central region and the peripheral region.
US07718005B2
Film forming equipment (20) is provided with a treatment container (22), a gas supplying system for supplying the container with a treatment gas including a film forming gas, and an exhaust system for exhausting the atmosphere in the container. In the treatment container, a placing table (46) having a placing plane for placing a flat board shaped body to be treated (W) is arranged. The body to be treated on the placing table is heated by a heater (80). A clamping apparatus (56) is provided to abut/separate to and from a surface peripheral part of the body to be treated, so as to press/release the body to be treated on and from the placing table. On the placing plane of the placing table, a suction structure (92) having a recessed part (94) is formed for temporarily sucking the body to be treated by pressure difference, by forming a substantially hermetic space between the placing plane and the rear plane of the body to be treated.
US07718002B2
A crystal manufacturing apparatus for manufacturing a group III nitride crystal includes a crucible that holds a mixed molten liquid including an alkali metal and a group III metal; a reaction vessel accommodating the crucible in the reaction vessel; a heating device that heats the crucible with the reaction vessel; a holding vessel having a lid that is capable of opening and closing, accommodating the reaction vessel and the heating device in the holding vessel; a sealed vessel accommodating the holding vessel in the sealed vessel, having an operating device that enables opening the lid of the holding vessel for supplying source materials into the crucible and taking out a manufactured GaN crystal under a sealed condition, and closing the lid of the holding vessel that is sealed in the sealed vessel, the sealed vessel including an inert gas atmosphere or a nitrogen atmosphere; and a gas supplying device for supplying a nitrogen gas to the mixed molten liquid through each of the vessels.
US07718000B2
One provides (101) disperse ultra-nanocrystalline diamond powder material that comprises a plurality of substantially ordered crystallites that are each sized no larger than about 10 nanometers. One then reacts (102) these crystallites with a metallic component. The resultant nanowire is then able to exhibit a desired increase with respect to its ability to conduct electricity while also substantially preserving the thermal conductivity behavior of the disperse ultra-nanocrystalline diamond powder material. The reaction process can comprise combining (201) the crystallites with one or more metal salts in an aqueous solution and then heating (203) that aqueous solution to remove the water. This heating can occur in a reducing atmosphere (comprising, for example, hydrogen and/or methane) to also reduce the salt to metal.
US07717996B2
A sprayable coating agent is disclosed in the form of granules with which the granules are compacted to form a pressed piece, subsequently ground up and optionally sieved, whereby the granules have the following particle-size distribution: 0%-40% by weight: 0-600 microns; 5%-55% by weight: 600-1250 microns; 5%-95% by weight: >1250 microns; or 15% by weight: 0-800 microns; 0%-85% by weight: 800-2000 microns; 0%-15% by weight: >2000 microns. Likewise disclosed are its production, further processing and use for internal and external applications.
US07717980B2
A contaminant extraction apparatus, systems and method for extracting contaminants, such as particles and polar molecules, from an air flow containing a contaminated gas such as air so that the contaminants are expelled from the embodiments after they are extracted. One method includes the steps of generating two electric fields in separate air flow channels separated by an extraction grid with the second electric field having a greater potential difference than the first electric field; generating a first air flow through the first air flow channel and a second air flow through a second air flow channel; dispensing charged liquid droplets into the first air flow using at least one charged droplet generator; allowing the droplets to transfer charge to those contaminants; and expelling the contaminants into the second air flow using the potential difference in the second electric field.
US07717977B2
The producing unit for continuously producing metal microparticles formed of a multicomponent alloy accompanied by the generation of a byproduct gas through an early reaction of the formation of the metal particles comprises a first mixing unit for continuously supplying and mixing a plurality of solutions for conducting the early reaction, a second mixing unit for continuously supplying another solution to the reaction liquid containing the metal microparticles formed in the early reaction and for mixing the two solutions, to introduce dissimilar metal atoms into the crystal lattices of the metal microparticles, and a gas-liquid separation unit that is installed in a midway of the pipe which is made so as to have enough length to finish the early reaction, and which continuously passes the reaction liquid to the second mixing unit from the first mixing unit, and that continuously removes the byproduct gas generated with the proceeding of the early reaction.
US07717976B2
A method for making a strain aging resistant steel comprises adding boron to the steel, wherein substantially all of the boron in the steel forms boron nitride. A method for making steel comprises adding a nitride-forming element to the steel to lower the free nitrogen content of the steel to a free nitrogen content specification. A high-carbon steel contains boron nitride, wherein the free nitrogen content of the steel is less than 80 ppm. A strain aging resistant steel wherein the carbon content of the steel is between about 0.54 percent and about 0.75 percent.
US07717973B2
A cyclone dust-separating apparatus includes a cyclone unit having air inflow and air outflow parts that separate dust or dirt from air, the cyclone unit being installed such that a longitudinal axis thereof is substantially horizontally arranged; a dust bin joined to a bottom end of the cyclone unit that collects the dust or dirt separated by the cyclone unit, the dust bin installed in such a manner that a longitudinal axis thereof is substantially perpendicular to the longitudinal axis of the cyclone unit; a nonporous envelope detachably disposed in the dust bin that stores the dust or dirt collected into the dust bin; and a pressure difference-generating passage to communicate an outlet of the air outflow part and the dust bin with each other so as to allow the nonporous envelope to come in contact with an inner surface of the dust bin by a pressure difference between the dust bin and the air outflow part.
US07717964B2
The disclosure relates to the dyeing of keratin materials using styryl hydroxy(cyclo)alkylamino thiol/disulfide fluorescent dyes. Disclosed herein is a dye composition comprising a styryl hydroxy(cyclo)alkylamino thiol/disulfide fluorescent dye and a dyeing process with, for example, a lightening effect on keratin materials such as hair, using said composition. Disclosed herein are novel thiol/disulfide fluorescent dyes and the uses thereof in lightening keratin materials. This composition makes it possible to obtain a lightening effect which can be resistant and visible on dark keratin fibers.
US07717958B2
A spinal mobility preservation apparatus and methods are disclosed. The spinal mobility preservation apparatus may include a proximal body, an intermediate body, a distal body, and an expandable membrane. The proximal body and the distal body secure the mobility preservation apparatus to adjacent vertebral bodies. At least one of an intermediate body and an expandable membrane secure the proximal body to the distal body and provide a degree of support to a spinal motion segment defined by the adjacent vertebral bodies. A single proximal body and an expandable membrane may also compose a spinal mobility preservation apparatus. The proximal body secured to one of a superior or an inferior vertebral body and the expandable membrane extending into the intervertebral disc space to support the spinal motion segment.
US07717941B2
A linking element for a spinal fixing system is designed to link at least two implantable connecting assemblies. The linking element is formed at least partly of a support made of polymeric material and of two rods with a first rod, bent or not, substantially coaxial with the support, and a second rod formed of turns surrounding the first rod with the turns being at least partly embedded in the support. A spinal fixing system has at least two implantable connecting assemblies linked by at least one linking element.
US07717936B2
A transvascular embolic protection system for safely capturing and retaining embolic material released during an interventional procedure comprises an embolic protection device (1) and a delivery catheter (2) for delivery of the embolic protection device (1) to a desired location in the vascular system. A pack (4) is provided to safely store and prepare the embolic protection system for use. The pack (4) comprises a tray (5) with a channel (6) extending in a looped configuration around the tray (5) for receiving the delivery catheter (2). A loading device (7) is mounted in the tray (5) adjacent to the delivery catheter (2). The embolic protection device (1) is mounted in an expanded configuration in a well (90) in the tray (5). A pushing device (8) for loading the collapsible embolic protection device (1) into the delivery catheter (2) is mounted in the tray (5) adjacent to the embolic protection device (1).
US07717934B2
Catheters, assemblies, and methods for delivering and recovering embolic protection devices. Catheters are provided that can be advanced over single length guide wires and which can be retracted over single length wire shafts of distal embolic protection devices. One catheter is a two-port catheter having two sidewall ports, a distal end port, and a proximal end port. The two-port catheter can be advanced over a guide wire threaded between the distal end port and the distal sidewall port. An embolic protection device wire shaft can be back loaded into the distal end port and out the proximal sidewall port. A three-port catheter includes a distal end port, and distal, intermediate, and proximal sidewall ports. The distal sidewall port can be dimensioned to accept passage of a filter body through the port. The distal end port can be dimensioned to accept only a guide wire to provide a smooth transition from the guide wire to the small profile distal end. The guide wire can extend between the distal end port and the intermediate port while the filter body shaft can extend through the proximal port, to be distally urged through the distal sidewall port. Another catheter embodiment is a slotted catheter, including a biased, normally open slot over most of its length. The slot can be sufficiently small to resist unwanted transverse movement of a wire through the slot. The slotted catheter can be retracted over a wire by forcing the wire through the resilient slot.
US07717928B2
A surgical tool which comprises an elongated body having a proximal end and a distal end, first and second sets of tissue approximating structures having deployed and retracted positions relative to the elongated body, an actuating mechanism extending from the proximal end of the elongated body for independently deploying and retracting each of the first and second sets of tissue approximating structures, a drainage lumen extending from a drainage aperture at the distal end of the elongated body to the proximal end, a main balloon adjacent to the distal end of the elongated body, and a strap connector extending from the elongated body that is connectable with a stabilization strap.
US07717923B2
Over-the-scope stent introducers for detachably engaging at least a portion of the outside of an endoscope insert and for delivering a stent are provided. Embodiments include an inner member having a distal first end portion and a proximal second end portion and openings defining a channel. The inner member includes an outer surface, inner endoscope engaging surface, and stent abutting restraint disposed at the first end portion. Embodiments also include an outer member having a distal section and proximal section having openings defining a passageway sized to slideably receive at least a portion of the inner member, and a stent carrying inner chamber disposed at the distal section passageway and being configured to releasably contain a stent. In alternative embodiments, the inner and outer members are elongated to dispose substantially concentrically over a majority of an endoscope insert.
US07717920B2
A prosthesis is installed in a cavity that traverses a joint between a talus and a calcaneus. The cavity is established by intramedullary guidance with respect to the major axis of the tibia by access through the calcaneus.
US07717916B2
An external fixation device for holding bone fragments in place includes a housing having a number of rotationally adjustable pin holders, each of which is held by a clamping member that simultaneously clamps the pin holder within an internal mounting surface of the housing and a bone pin within the pin holder. A first embodiment includes a number of internal mounting surfaces, each of which can include a single pin holder. A second embodiment includes one or two internal mounting surfaces, each of which holds a row of pin holders that is clamped in place by a single clamping member.
US07717915B2
An ultrasonic coagulation and cutting apparatus includes: an ultrasonic transducer for a treatment using ultrasonic vibrations on body tissue; a probe for transmitting generated ultrasonic vibrations to the distal end thereof; a movable gripping member for cooperating with the outer surface of the probe in gripping therebetween body tissue; an operation unit operated to move the gripping member; an operation transmitting member for transmitting the operation of the operation unit to the gripping member; and high frequency power supply connecting portions for electrically connecting the probe and the gripping member to predetermined portions of a high frequency power supply for a treatment using high frequency current on the body tissue. At least coagulation of the body tissue using high frequency current is started in a first gripping state. Cutting of the body tissue using ultrasonic vibrations generated by the ultrasonic transducer is started in a second gripping state.
US07717913B2
A surgical instrument comprises, in accordance with the present invention, an elongate probe, a sleeve, a sleeve extension and at least one cauterization electrode. The probe is an ultrasonic element, serving to convey ultrasonic vibrations (as standing waves) to organic tissues at a surgical site. The probe has a working tip and a longitudinal axis. The sleeve surrounds the probe with the working tip of the probe projecting from a distal or free end of the sleeve. The sleeve extension is disposed at the distal or free end of the sleeve and defines a multiplicity of apertures having respective axes oriented at least substantially parallel to the longitudinal axis. The electrode has a distal or free end removably inserted through one of the apertures.
US07717912B2
The present invention provides systems, apparatus and methods for selectively applying electrical energy to body tissue in order to ablate, contract, coagulate, or otherwise modify a target tissue or organ. The closed configuration is adapted for clamping and coagulating a target tissue while the apparatus is operating in the sub-ablation mode, while the open configuration is adapted for ablating the target tissue via molecular dissociation of tissue components. A method of the present invention comprises clamping a target tissue or organ with an electrosurgical probe. A first high frequency voltage is applied between the active electrode and the return electrode to effect coagulation of the clamped tissue. Thereafter, a second high frequency voltage is applied to effect localized molecular dissociation of the coagulated tissue.
US07717905B2
A system and method for performing laser induced optical breakdown (LIOB) in corneal tissue of an eye requires calculating a pattern of focal spots. LIOB is then induced at a first focal spot, and is continued at a plurality of interim focal spots within a time period τ. Each focal spot has a diameter “d1” and generates a temporal cavitation bubble of diameter “d2”. It then collapses within time “τ” to a substantially stationary diameter “d3”, with (d1≦d3≦d2). Importantly, each focal spot is located more than “d2” from every other interim focal spot within the time period of “τ”. At the time “τ”, a second focal spot in the pattern can be generated at a distance “d3” from the first focal spot. This process is then continued with another plurality of interim focal spots being generated within another time period “τ”.
US07717902B2
A catheter for draining urine from the bladder and which is composed of a flexible plastic tube (1) having an insertion aid (2) secured to the insertion end of the tube. Thus the insertion aid and tube may be inserted into the urethra and guided therethrough into the bladder. The tube (1) has at least one orifice (4) in the region adjacent the insertion aid (2). Also, the insertion aid (2) connects with essentially the same diameter to the tube (1) and ends with a rounded head portion (3), whose diameter may be slightly larger than the diameter of the tube (1). The insertion aid may be significantly more flexible as compared to the tube.
US07717897B2
A flexible non-PVC, non-DEHP polyolefin container or bag for medical fluids has an elongated container body formed of polyolefin film. The container has one or more ports equipped with a polyolefin fill tube and port closure assembly. The container includes a concave seam on at least one of its longitudinal sides.
US07717894B2
A liquid-absorbent sheet containing: a liquid-absorbent surface material mainly containing a pulp; a liquid-absorbent nonwoven fabric; a liquid-absorbent rear material mainly containing a pulp; and a super absorbent polymer; wherein the super absorbent polymer is disposed at least between the liquid-absorbent surface material and the liquid-absorbent nonwoven fabric as an A layer and between the liquid-absorbent nonwoven fabric and the liquid-absorbent rear material as a B layer, the super absorbent polymer being contained in a total amount of 200 to 400 g/m2, which is allocated in the A layer at 30 to 50% by mass, the liquid-absorbent nonwoven fabric layer at 0 to 40% by mass, and the B layer at 30 to 70% by mass, and the content ratio of the super absorbent polymer in the A layer is less than or equal to the content ratio of the super absorbent polymer in the B layer.
US07717888B2
The Huber needle is drawn into a protective cap and sheath arrangement after use for disposal purposes. The cap is tethered to a housing in which the needle is mounted by the sheath. The sheath is made of a film material that has a high tensile strength and a low percent of elongation, such as polyester. The sheath is initially mounted about the needle in a collapsed accordion-like condition between the cap and housing. When the cap is moved along the needle, the sheath is played out over the needle. The cap houses a spring clip to snap over a bore through which the needle is retracted to prevent re-emergence of the needle. The flexible nature of the sheath allows the sheath to pass about the two legs of the Huber needle.
US07717886B2
A closed system, needleless valve device includes a generally tubular body defining an internal cavity. On the proximal end of the body there is an opening which is preferably sufficiently large to receive an ANSI standard tip of a medical implement. The distal end of the body has a generally tubular skirt. The valve also includes a hollow spike having a closed tip. The spike includes at least one longitudinal 18-gauge hole located distal the tip, and is seated inside the cavity such that the tip is below the proximal end of the body. An annular support cuff is connected to the spike which seals off a portion of the cavity of the body such that an upper cavity containing the tip is defined. The valve also includes a plastic, resilient silicone seal which fills the upper cavity and opening and covers the tip of the spike so as to present a flush surface. An adaptor enables the valve to be attached to a resealable container.
US07717876B2
The invention relates to a perfected retractable needle safety syringe comprising a hollow cylinder, a needle holder, a needle and a piston with an operating stem, said stem exhibiting an axial hole wherein there are seated a retraction pre-loaded spring and an extractor element. The extractor element exhibits a recess or seat intended for interacting with the needle holder, and at the side opposite the needle holder, a projection or annular rib.
US07717875B2
A hydraulically assisted actuator in a handle connects with a catheter having a deflectable distal ablation tip. The hydraulic actuator translates small mechanical movement by a clinician into large travel movements of connected steering cables and increased tension in the ablation tip for greater deflection. The hydraulic system further dampens the return of the ablation tip from a deflected position to an equilibrium position. The hydraulic actuation system is also incorporated into a set of foot pedals.
US07717865B2
A side loading, wire torquing device includes a body portion having a channel in which a wire is fitted. In one embodiment, a slider is movable along the channel to secure the wire between the slider and the fixed surface in the channel such that rotation of the torquing device rotates the wire therein. In another embodiment of the invention, the torquing device includes a bottom and top section folded over a wire. In another embodiment, the channels impart a bend to the wire to increase the effective torque that can be applied to the wire by rotating the device. In yet another embodiment, the torquing device has a tapered shape and includes a ring that is slideable over the device to compress a wire in a channel. In all embodiments, the torquing device may include a clip to secure several looped coils of wire when not in use.
US07717860B2
An elliptical biopsy guide comprises a platform and a pair of wings extending from the platform. Each of the wings terminates in a respective curved member. The platform defines a plane, and comprises beveled aperture edges defining an aperture. Each of the aperture edges has a generally elliptical curvature. Each of the wings is angled relative to the plane defined by the platform. A user may exert outward forces with first and second fingers against the insides of respective curved members to hold the elliptical biopsy guide. The elliptical biopsy guide may be positioned over a biopsy site, and a downward force may be applied with the elliptical biopsy guide to provide skin tension or hemostasis. The aperture may be used as a template for excising tissue at the biopsy site.
US07717859B2
A combination electronic communication and medical diagnostic apparatus includes a first component for transmitting or receiving a remote communication signal and a second component for generating vibration to be used in a medical diagnosis. The apparatus functions as a beeper/pager or cellular phone, as well as a medical diagnostic tool to detect and/or monitor neuropathy.
US07717858B2
Apparatus for improving health of a user is provided, including a first sensor, adapted to measure a first physiological variable, which is indicative of a voluntary action of the user. A second sensor is adapted to measure a second physiological variable, which is substantially governed by an autonomic nervous system of the user. Circuitry is adapted to receive respective first and second sensor signals from the first and second sensors, and, responsive thereto, to generate an output signal which directs the user to modify a parameter of the voluntary action.
US07717853B2
A method for delivering ultrasound energy to a patient's intracranial space involves forming at least one hole in the patient's skull, advancing at least one ultrasound delivery device at least partway through the hole(s), and transmitting ultrasound energy from the ultrasound delivery device(s). According to various embodiments, ultrasound delivery devices may be advanced into the epidural space, one or both ventricles and/or an intracerebral space of the patient's brain. In alternative embodiments, one or multiple holes may be formed in the skull, and any number of ultrasound delivery devices may be used. Intracranial ultrasound delivery may be used in diagnostic or therapeutic treatment of ischemic stroke, head trauma, atherosclerosis, perfusion disorders and other acute or chronic neurological conditions.
US07717850B2
The visibility of features in ultrasound images that include at least two types of tissue can be improved by processing the images using a variety of algorithms. In one such algorithm, the ratio of power in a first spatial frequency band to power in a second spatial frequency band is computed for a plurality of samples of a received ultrasound return signal that are associated with a given pixel. In another such algorithm, the ratio of power in a first spatial frequency band to total power is computed. With both algorithms, the computed ratio is then mapped to a gain for the given pixel, the raw intensity of the given pixel is modified in accordance with the gain, and the pixel is displayed with the modified intensity.
US07717840B2
The present invention relates to a soft roll material-translating device for the mechanical apparatus of machining and cutting after severing. The existing pillow type of automatic packing machine can only pack produces using one single roll of film, so the work efficiency is low. Consequently, the present invention aims at improving the work efficiency and it adopts following technical solutions: the soft roll material-translating device includes a frame (1), a right rotating unit (3) with right folding rod pair (5) and a left rotating unit (2) with left folding rod pair (4) are mounted on the frame (1), the right rotating unit (3) and the left rotating unit (2) can both rotate around a rotating center. By adding a few of mechanisms, the work efficiency of the device can be multiplied one times.
US07717837B2
Facilitating exercise using easy to transport and easy to assemble components and, when assembled, providing a portable apparatus on which a human can engage in a wide variety of exercises. Support elements including vertical components are supported on bases. Collars slideably insert over the support elements and further include bar supports for receiving one or more stabilizers. The stabilizers join the support elements and the bases forming a system base.
US07717836B1
Exercise apparatus is provided with a system for collapsing a user seat to a stow-away position. A user-engaged locking device releasably locks a bearing assembly and a seat frame at each of a user-exercise position and a stow-away position.